These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10702221)

  • 1. Agouti and agouti-related protein: analogies and contrasts.
    Dinulescu DM; Cone RD
    J Biol Chem; 2000 Mar; 275(10):6695-8. PubMed ID: 10702221
    [No Abstract]   [Full Text] [Related]  

  • 2. The yellow mouse obesity syndrome and mechanisms of agouti-induced obesity.
    Moussa NM; Claycombe KJ
    Obes Res; 1999 Sep; 7(5):506-14. PubMed ID: 10509609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pharmacology of Agouti protein in vitro and in vivo.
    Barsh GS; Ollmann MM; Wilson BD; Miller KA; Gunn TM
    Ann N Y Acad Sci; 1999 Oct; 885():143-52. PubMed ID: 10816647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From Agouti to Pomc--100 years of fat blonde mice.
    Barsh G
    Nat Med; 1999 Sep; 5(9):984-5. PubMed ID: 10470066
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice.
    Shutter JR; Graham M; Kinsey AC; Scully S; Lüthy R; Stark KL
    Genes Dev; 1997 Mar; 11(5):593-602. PubMed ID: 9119224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common requirements for melanocortin-4 receptor selectivity of structurally unrelated melanocortin agonist and endogenous antagonist, Agouti protein.
    Oosterom J; Garner KM; den Dekker WK ; Nijenhuis WA; Gispen WH; Burbach JP; Barsh GS; Adan RA
    J Biol Chem; 2001 Jan; 276(2):931-6. PubMed ID: 11024027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanocortin receptor binding determinants in the agouti protein.
    Kiefer LL; Veal JM; Mountjoy KG; Wilkison WO
    Biochemistry; 1998 Jan; 37(4):991-7. PubMed ID: 9454589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the agouti gene in the yellow obese syndrome.
    Miltenberger RJ; Mynatt RL; Wilkinson JE; Woychik RP
    J Nutr; 1997 Sep; 127(9):1902S-1907S. PubMed ID: 9278579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of melanocortin receptor signaling mediated by the amino terminus of Agouti protein in Xenopus melanophores.
    Ollmann MM; Barsh GS
    J Biol Chem; 1999 May; 274(22):15837-46. PubMed ID: 10336487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agouti/melanocortin interactions with leptin pathways in obesity.
    Zemel MB
    Nutr Rev; 1998 Sep; 56(9):271-4. PubMed ID: 9763877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanocortin receptors and antagonists regulate pigmentation and body weight.
    Jordan SA; Jackson IJ
    Bioessays; 1998 Aug; 20(8):603-6. PubMed ID: 9780833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel agouti-related-protein-based melanocortin-1 receptor antagonist.
    Thirumoorthy R; Holder JR; Bauzo RM; Richards NG; Edison AS; Haskell-Luevano C
    J Med Chem; 2001 Nov; 44(24):4114-24. PubMed ID: 11708914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Agouti-related protein binding to melanocortin receptors.
    Yang YK; Thompson DA; Dickinson CJ; Wilken J; Barsh GS; Kent SB; Gantz I
    Mol Endocrinol; 1999 Jan; 13(1):148-55. PubMed ID: 9892020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A synthetic human Agouti-related protein-(83-132)-NH2 fragment is a potent inhibitor of melanocortin receptor function.
    Quillan JM; Sadée W; Wei ET; Jimenez C; Ji L; Chang JK
    FEBS Lett; 1998 May; 428(1-2):59-62. PubMed ID: 9645475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agouti regulation of intracellular calcium: role of melanocortin receptors.
    Kim JH; Kiefer LL; Woychik RP; Wilkison WO; Truesdale A; Ittoop O; Willard D; Nichols J; Zemel MB
    Am J Physiol; 1997 Mar; 272(3 Pt 1):E379-84. PubMed ID: 9124542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological and anatomical circuitry between Agouti-related protein and leptin signaling.
    Wilson BD; Bagnol D; Kaelin CB; Ollmann MM; Gantz I; Watson SJ; Barsh GS
    Endocrinology; 1999 May; 140(5):2387-97. PubMed ID: 10218993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome.
    Fan W; Boston BA; Kesterson RA; Hruby VJ; Cone RD
    Nature; 1997 Jan; 385(6612):165-8. PubMed ID: 8990120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An agouti mutation lacking the basic domain induces yellow pigmentation but not obesity in transgenic mice.
    Miltenberger RJ; Mynatt RL; Bruce BD; Wilkison WO; Woychik RP; Michaud EJ
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8579-84. PubMed ID: 10411918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accessory proteins for melanocortin signaling: attractin and mahogunin.
    He L; Eldridge AG; Jackson PK; Gunn TM; Barsh GS
    Ann N Y Acad Sci; 2003 Jun; 994():288-98. PubMed ID: 12851328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the carboxyl terminus of the agouti protein decrease agouti inhibition of ligand binding to the melanocortin receptors.
    Kiefer LL; Ittoop OR; Bunce K; Truesdale AT; Willard DH; Nichols JS; Blanchard SG; Mountjoy K; Chen WJ; Wilkison WO
    Biochemistry; 1997 Feb; 36(8):2084-90. PubMed ID: 9047307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.